Skip to main content
Full-Length Research Report

SKT Short Cognitive Performance Test and Activities of Daily Living in Dementia

Published Online:https://doi.org/10.1024/1662-9647/a000104

Using data from two randomized, placebo-controlled trials involving 806 outpatients, we performed linear regression analyses to evaluate how cognitive abilities in patients with dementia assessed by the SKT (Syndrom-Kurztest – Short Cognitive Performance Test) correlate with activities of daily living rated by means of the Activities of Daily Living International Scale (ADL-IS). There were significant correlations between SKT total score and ADL-IS total mean score at baseline (r = 0.52, p < .001) as well as between change in SKT total score and change in ADL-IS total mean score during the 24-week treatment period (r = 0.48, p < .001). Significant correlations with ADL-IS total mean scores were also found for both memory and attention/concentration subscores of the SKT.

References

  • Choi, S. H., Lee, B. H., Hahm, D. S., Jeong, J. H., Ha, C. K., Han, S. H. , ... Na, D. L. (2004). Validation of the Korean version of the Syndrom Kurztest (SKT): A short test for the assessment of memory and attention. Human Psychopharmacology Clinical and Experimental, 19, 495–501. First citation in articleCrossrefGoogle Scholar

  • Cummings, J. L. (1997). The Neuropsychiatric Inventory: Assessing psychopathology in dementia patients. Neurology, 48(Suppl. 6), S10–S16. First citation in articleGoogle Scholar

  • European Agency for the Evaluation of Medicinal Products (1997). Note for guidance on medicinal products in the treatment of Alzheimer’s disease (CPMP/EWP/553/95 Corr.). London: European Medicines Evaluation Agency. First citation in articleGoogle Scholar

  • European Medicines Agency . (2008). Guideline on medicinal products for the treatment of Alzheimer’s disease and other dementias (CPMP/EWP/553/95 Rev. 1). London: European Medicineds Agency. First citation in articleGoogle Scholar

  • Erzigkeit, H. (1986). Manual zum SKT Formen A-E. Ein Kurztest zur Erfassung von Aufmerksamkeits- und Gedächtnisstörungen [SKT manual forms A-E. A short performance test to assess impairment of attention and memory]. Ebersberg: Vless-Verlag. First citation in articleGoogle Scholar

  • Flaks, M. K., Regina, A. C. B., Cid, C. G., Yassuda, M. S., Camargo, C. H. P., Forlenza, O. V. (2004). The Short Cognitive Test (SKT) – A transcultural test for early detection and discrimination of dementia: A preliminary study in Brazil. Neurobiology of Aging, 25(Suppl. 2), 113. First citation in articleCrossrefGoogle Scholar

  • Fornazzari, L., Cumsille, F., Quevedo, F., Quiroga, P., Rioseco, P., Klaasen, G. , ... Flaskamp, R. (2001). Spanish validation of the Syndrom Kurztest (SKT). Alzheimer Disease and Associated Disorders, 15, 211–215. First citation in articleCrossrefGoogle Scholar

  • Hallikainen, I., Koivisto, A. M., Paajanen, T., Hiltunen, A., Karppi, P., Vanhanen, M. , ... Hänninen, T. (2012). Cognitive and neuropsychiatric symptom differences in early stages of Alzheimer’s disease: Kuopio ALSOVA Study. Dementia and Geriatric Cognitive Disorders Extra, 2, 209–218. First citation in articleCrossrefGoogle Scholar

  • Herrmann, W. M., Stephan, K. (1992). Moving from the question of efficacy to the question of therapeutic relevance: an exploratory reanalysis of a controlled clinical study of 130 inpatients with dementia syndrome taking piracetam. International Psychogeriatrics, 4, 25–43. First citation in articleCrossrefGoogle Scholar

  • Herrschaft, H., Nacu, A., Likhachev, S., Sholomov, I., Hoerr, R., Schlaefke, S. (2012). Ginkgo biloba extract EGb 761® in dementia with neuropsychiatric features: A randomized, placebo-controlled trial to confirm the efficacy and safety of a daily dose of 240 mg. Journal of Psychiatric Research, 46, 716–723. First citation in articleCrossrefGoogle Scholar

  • Ihl, R., Bachinskaya, N., Korczyn, A., Vakhapova, V., Tribanek, M., Hoerr, R., Napryeyenko, O., on behalf of the GOTADAY Study Group. (2011). Efficacy and safety of a once-daily formulation of Ginkgo biloba extract EGb 761 in dementia with neuropsychiatric features: A randomized controlled trial. International Journal of Geriatric Psychiatry, 26, 1186–1194. First citation in articleGoogle Scholar

  • Kim, Y. S., Nibbelink, D. W., Overall, J. E. (1993). Factor structure and scoring of the SKT test battery. Journal of Clinical Psychology, 49, 61–71. First citation in articleCrossrefGoogle Scholar

  • Lehfeld, H., Rudinger, G., Rietz, C., Heinrich, C., Wied, V., Fornazzari, L. , ... Erzigkeit, H. (1997). Evidence of the cross-cultural stability of the factor structure of the SKT short test for assessing deficits of memory and attention. International Psychogeriatrics, 9, 139–153. First citation in articleCrossrefGoogle Scholar

  • Mahoney, R., Johnston, K., Katona, C., Maxmin, K., Livingston, G. (2005). The TE4D-Cog: A new test for detecting early dementia in English-speaking populations. International Journal of Geriatric Psychiatry, 20, 1172–1179. First citation in articleCrossrefGoogle Scholar

  • McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., Stadlan, E. M. (1984). Clinical diagnosis of Alzheimer’s disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology, 34, 939–944. First citation in articleGoogle Scholar

  • Ostrosky-Solís, F., Dávila, G., Ortiz, X., Vega, F., Ramos, G. G., de Celis, M. , ... Molina, B. (1999). Determination of normative criteria and validation of the SKT for use in Spanish-speaking populations. International Psychogeriatrics, 11, 171–180. First citation in articleCrossrefGoogle Scholar

  • Reisberg, B., Finkel, S., Overall, J., Schmidt-Gollas, N., Kanowski, S., Lehfeld, H. , ... Erzigkeit, H. (2001). The Alzheimer’s Disease Activities of Daily Living International Scale (ADL-IS). International Psychogeriatrics, 13, 163–181. First citation in articleCrossrefGoogle Scholar

  • Reppermund, S., Sachdev, P. S., Crawford, J., Kochan, N. A., Slavin, M. J., Kang, K. , ... Brodaty, H. (2011). The relationship of neuropsychological function to instrumental activities of daily living in mild cognitive impairment. International Journal of Geriatric Psychiatry, 26, 843–852. First citation in articleCrossrefGoogle Scholar

  • Rockwood, K., Fay, S., Gorman, M. (2010). The ADAS-cog and clinically meaningful change in the VISTA clinical trial of galantamine for Alzheimer’s disease. International Journal of Geriatric Psychiatry, 25, 191–201. First citation in articleCrossrefGoogle Scholar

  • Román, G. C., Tatemichi, T. K., Erkinjuntti, T., Cummings, J. L., Masdeu, J. C., Garcia, J. H. , ... Scheinberg, P. (1993). Vascular dementia: Diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology, 43, 250–260. First citation in articleGoogle Scholar

  • Royall, D. R., Lauterbach, E. C., Kaufer, D., Malloy, P., Coburn, K. L., Black, K. J. , Committee on Research of the American Neuropsychiatric Association. (2007). The cognitive correlates of functional status: a review from the Committee on Research of the American Neuropsychiatric Association. The Journal of Neuropsychiatry and Clinical Neurosciences, 19, 249–265. First citation in articleCrossrefGoogle Scholar

  • Steffens, D. C., Maytan, M., Helms, M. J., Plassman, B. L. (2005). Prevalence and clinical correlates of neuropsychiatric symptoms in dementia. American Journal of Alzheimer’s Disease and Other Dementias, 20, 367–373. First citation in articleCrossrefGoogle Scholar

  • Stemmler, M., Horn, R., Lehfeld, H., Petermann, F., Siebert, J. (2013). Entwicklungsdiagnostik im Alter: Wie kann man unauffällige Leistungen von auffälligen unterscheiden? [Developmental psychological assessment of aging: How can we differentiate normal from abnormal cognitive achievements?]. Diagnostica, 59, 1–10. First citation in articleLinkGoogle Scholar

  • Tekin, S., Fairbanks, L. A., O’Connor, S., Cummings, J. L. (2001). Activities of daily living in Alzheimer’s disease: Neuropsychiatric, cognitive and medical illness influences. American Journal of Geriatric Psychiatry, 9, 81–86. First citation in articleCrossrefGoogle Scholar